GCC19CART Demonstrates Preliminary Antitumor Activity in Refractory mCRC
https://www.ictbio.com/wp-content/uploads/2022/04/ictbio-6.jpg
1000
667
Innovative Cellular Therapeutics
https://www.ictbio.com/wp-content/uploads/2022/04/ictbio-6.jpg
GCC19CART Demonstrates Preliminary Antitumor Activity in Refractory mCRC
This article is reprinted from OncLive. The original li…